INTRODUCTION
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
Preclinical Evaluation
7 Topics | 4 Quizzes
Biostatistics
19 Topics | 10 Quizzes
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
SESSION VII: TRANSLATIONAL PATHWAY FOR INTERVENTIONAL DEVICES FOR HEART FAILURE
SESSION VIII: TRANSLATIONAL PATHWAY FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES
1 of 2

Translational Pathway to Expedite Scientific Discovery to Patients


Robert Califf, MD, FDA

Food and Drug Administration

Learning Objectives

  • Recognize that creativity and innovation are critical for our patients and economy
  • Recognize the future of merging technology of devices, biologics and drugs
  • Understand the importance of precision medicine
  • Understand the concept of ecosystem
  • Learn the concept of integrated health system
  • Learn the importance of the preclinical data
  • Learn that evidence collected should be useful for FDA and CMS approval at the same time
  • Recognize the importance of sharing data
Hide picture